These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8961850)

  • 21. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency.
    Clark NP
    Thromb Res; 2008; 123 Suppl 1():S58-61. PubMed ID: 18809206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
    Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA
    Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosing of unfractionated heparin in obese patients with venous thromboembolism.
    Hurewitz AN; Khan SU; Groth ML; Patrick PA; Brand DA
    J Gen Intern Med; 2011 May; 26(5):487-91. PubMed ID: 21161426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital.
    de Groot MR; Büller HR; ten Cate JW; van Marwijk Kooy M
    Thromb Haemost; 1998 Jul; 80(1):70-3. PubMed ID: 9684788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfractionated heparin dosing in obese patients.
    George C; Barras M; Coombes J; Winckel K
    Int J Clin Pharm; 2020 Apr; 42(2):462-473. PubMed ID: 32140914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous administration of heparin in patients with deep vein thrombosis can increase plasma levels of diamine oxidase.
    Klocker J; Perkmann R; Klein-Weigel P; Mörsdorf G; Drasche A; Klingler A; Fraedrich G; Schwelberger HG
    Vascul Pharmacol; 2004 Jan; 40(6):293-300. PubMed ID: 15063833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.
    Reiff DA; Haricharan RN; Bullington NM; Griffin RL; McGwin G; Rue LW
    J Trauma; 2009 May; 66(5):1436-40. PubMed ID: 19430251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial treatment of venous thromboembolism.
    Becattini C; Agnelli G; Emmerich J; Bura A; Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):242-50. PubMed ID: 16953263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight-based heparin dosing is more effective in the treatment of postoperative deep vein thrombosis.
    Linke LC; Katthagen BD
    Arch Orthop Trauma Surg; 1999; 119(3-4):208-11. PubMed ID: 10392521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
    Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
    Kearon C
    Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke.
    Toth C; Voll C
    Stroke; 2002 Mar; 33(3):670-4. PubMed ID: 11872885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients.
    Spruill WJ; Wade WE; Huckaby WG; Leslie RB
    Am J Health Syst Pharm; 2001 Nov; 58(22):2143-6. PubMed ID: 11760916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.